Literature DB >> 826265

Plasma hormone levels and the incidence of carcinogen-induced mammary tumours in two strains of rat.

R A Hawkins, D Drewitt, B Freedman, E Killin, D A Jenner, E H Cameron.   

Abstract

The incidence of mammary tumours developing after administration of the carcinogen DMBA (at 50 days of age) has been determined in 2 strains of Sprague-Dawley rat. Untreated animals of each strain were exsanguinated in dioestrus at a time corresponding to the early post-carcinogen stage (at 70 days of age) and the plasma concentrations of prolactin, oestradiol-17B and progesterone were measured by radioimmunoassay. In an inbred strain of rats, tumour-induction rate was 6-4% and plasma prolactin concentration was 2-5 x lower than that found in a random-bred strain with a tumour-induction rate of 41-6%. No difference was found between the 2 strains in the level of either ovarian hormone. It is concluded that the difference between these strains in mammary gland susceptibility to DMBA may be related to plasma prolactin concentration, but it is unlikely to be determined by the ovarian hormones.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826265      PMCID: PMC2025204          DOI: 10.1038/bjc.1976.209

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  MAMMARY TUMOR INDUCTION BY ESTROGEN OR ANTERIOR PITUITARY HORMONES IN OVARIECTOMIZED RATS GIVEN 7, 12-DIMETHYL-1, 2-BENZANTHRACENE.

Authors:  P K TALWALKER; J MEITES; H MIZUNO
Journal:  Proc Soc Exp Biol Med       Date:  1964-06

2.  Effect of dose and hormones on tumor production in rats given emulsified 9, 10-dimethyl-1,2-benzanthracene intravenously.

Authors:  R P GEYER; J E BRYANT; V R BLEISCH; E M PEIRCE; F J STARE
Journal:  Cancer Res       Date:  1953-07       Impact factor: 12.701

3.  Mammary neoplasia in Sprague-Dawley or Long-Evans rats after in vitro 7, 12-dimethylbenz(alpha) anthracene.

Authors:  R D Brown; C J Shellabarger
Journal:  Cancer Res       Date:  1974-10       Impact factor: 12.701

4.  Effect of neonatally administered estrogen or prolactin on normal and neoplastic mammary growth and serum estradiol-17 beta level in rats.

Authors:  H Nagasawa; R Yanai; M Shodono; T Nakamura; Y Tanabe
Journal:  Cancer Res       Date:  1974-10       Impact factor: 12.701

5.  Influence of nursing on the release of prolactin and GH in mice with high and low incidence of mammary tumors.

Authors:  Y N Sinha; C B Salocks; U J Lewis; W P VanderLaan
Journal:  Endocrinology       Date:  1974-10       Impact factor: 4.736

6.  An improved method for the preparation of iodinated antigens for radioimmunoassay.

Authors:  M R Redshaw; S S Lynch
Journal:  J Endocrinol       Date:  1974-03       Impact factor: 4.286

7.  The natural history of prolactin and GH secretion in mice with high and low incidence of mammary tumors.

Authors:  Y N Sinha; F W Selby; W P Vanderlaan
Journal:  Endocrinology       Date:  1974-03       Impact factor: 4.736

8.  Correlation between serum prolactin levels and incidence of mammary tumors induced by 7,12-dimethylbenz(alpha)anthracene in the rat.

Authors:  R R Gala; S J Loginsky
Journal:  J Natl Cancer Inst       Date:  1973-08       Impact factor: 13.506

9.  Radioimmunoassay of plasma progesterone.

Authors:  E H Cameron; J J Scarisbrick
Journal:  Clin Chem       Date:  1973-12       Impact factor: 8.327

10.  Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors.

Authors:  C HUGGINS; G BRIZIARELLI; H SUTTON
Journal:  J Exp Med       Date:  1959-01-01       Impact factor: 14.307

View more
  5 in total

1.  Prolactin levels and molecular heterogeneity in rat strains with high and low incidence of DMBA-induced mammary tumors.

Authors:  D M Lawson; N Sensui; D H Haisenleder; P N Kaufman; R R Gala
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

2.  Endocrinologic milieu and susceptibility of the rat mammary gland to carcinogenesis.

Authors:  D R Ciocca; A Parente; J Russo
Journal:  Am J Pathol       Date:  1982-10       Impact factor: 4.307

3.  Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17 beta.

Authors:  M A Blankenstein; J J Broerse; M J van Zwieten; H J van der Molen
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

4.  Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo.

Authors:  D E Blask; D B Pelletier; S M Hill; A Lemus-Wilson; D S Grosso; S T Wilson; M E Wise
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 5.  Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis.

Authors:  J Russo; L K Tay; D R Ciocca; I H Russo
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.